Document is current
Any future updates will be listed below
-
Authors
Neavin, Drew
Senabouth, Anne
Arora, Himanshi
Lee, Jimmy Tsz Hang
Ripoll-Cladellas, Aida
,
Franke, Lude
Prabhakar, Shyam
Ye, Chun Jimmie
McCarthy, Davis J.
Melé, Marta
Hemberg, Martin
Powell, Joseph E. https://orcid.org/0000-0002-5070-4124
- License Information
-
More Information
Article History
Received: 7 March 2023
Accepted: 25 March 2024
First Online: 15 April 2024
Declarations
:
: Briefly, all work was approved by the Royal Hobart Hospital, the Hobart Eye Surgeons Clinic, Human Research Ethics Committees of the Royal Victorian Eye and Ear Hospital (11/1031), University of Melbourne (1545394) and University of Tasmania (H0014124) in accordance with the requirements of the National Health & Medical Research Council of Australia (NHMRC) and conformed with the Declaration of Helsinki [].
: No personal data for any individual requiring consent for publication was included in this manuscript.
: C.J.Y. is founder for and holds equity in DropPrint Genomics (now ImmunAI) and Survey Genomics, a Scientific Advisory Board member for and holds equity in Related Sciences and ImmunAI, a consultant for and holds equity in Maze Therapeutics, and a consultant for TReX Bio, HiBio, ImYoo, and Santa Ana. Additionally, C.J.Y is also newly an Innovation Investigator for the Arc Institute. C.J.Y. has received research support from Chan Zuckerberg Initiative, Chan Zuckerberg Biohub, Genentech, BioLegend, ScaleBio and Illumina.
